117 related articles for article (PubMed ID: 19623026)
1. Plasma procalcitonin is an independent predictor of graft failure late after renal transplantation.
van Ree RM; de Vries AP; Oterdoom LH; Seelen MA; Gansevoort RT; Schouten JP; Struck J; Navis G; Gans RO; van der Heide JJ; van Son WJ; Bakker SJ
Transplantation; 2009 Jul; 88(2):279-87. PubMed ID: 19623026
[TBL] [Abstract][Full Text] [Related]
2. Influence of C-reactive protein and urinary protein excretion on prediction of graft failure and mortality by serum albumin in renal transplant recipients.
van Ree RM; Gross S; Zelle DM; van der Heide JJ; Schouten JP; van Son WJ; Gans RO; Bakker SJ
Transplantation; 2010 May; 89(10):1247-54. PubMed ID: 20559032
[TBL] [Abstract][Full Text] [Related]
3. Procalcitonin, a donor-specific predictor of early graft failure-related mortality after heart transplantation.
Wagner FD; Jonitz B; Potapov EV; Qedra N; Wegscheider K; Abraham K; Ivanitskaia EA; Loebe M; Hetzer R
Circulation; 2001 Sep; 104(12 Suppl 1):I192-6. PubMed ID: 11568054
[TBL] [Abstract][Full Text] [Related]
4. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin.
Sitter T; Schmidt M; Schneider S; Schiffl H
J Nephrol; 2002; 15(3):297-301. PubMed ID: 12113602
[TBL] [Abstract][Full Text] [Related]
5. Procalcitonin in the early phase after renal transplantation--will it add to diagnostic accuracy?
Eberhard OK; Langefeld I; Kuse ER; Brunkhorst FM; Kliem V; Schlitt HJ; Pichlmayr R; Koch KM; Brunkhorst R
Clin Transplant; 1998 Jun; 12(3):206-11. PubMed ID: 9642511
[TBL] [Abstract][Full Text] [Related]
6. Nonesterified fatty acids and development of graft failure in renal transplant recipients.
Klooster A; Hofker HS; Navis G; Homan van der Heide JJ; Gans RO; van Goor H; Leuvenink HG; Bakker SJ
Transplantation; 2013 Jun; 95(11):1383-9. PubMed ID: 23524974
[TBL] [Abstract][Full Text] [Related]
7. Utility of procalcitonin as a biomarker for rejection and differentiation of infectious complications in lung transplant recipients.
Sammons C; Doligalski CT
Ann Pharmacother; 2014 Jan; 48(1):116-22. PubMed ID: 24259617
[TBL] [Abstract][Full Text] [Related]
8. Comparison of procalcitonin and C-reactive protein as markers of sepsis.
Luzzani A; Polati E; Dorizzi R; Rungatscher A; Pavan R; Merlini A
Crit Care Med; 2003 Jun; 31(6):1737-41. PubMed ID: 12794413
[TBL] [Abstract][Full Text] [Related]
9. The clinical value of procalcitonin and neopterin in predicting sepsis and organ failure after major trauma.
Hensler T; Sauerland S; Lefering R; Nagelschmidt M; Bouillon B; Andermahr J; Neugebauer EA
Shock; 2003 Nov; 20(5):420-6. PubMed ID: 14560105
[TBL] [Abstract][Full Text] [Related]
10. Relationship between procalcitonin values and infection in brain-dead organ donors.
Rangeard O; Audibert G; Perrier JF; Loos-Ayav C; Lalot JM; Agavriloaie M; Meistelman C; Grégoire H; Mertes PM; Longrois D
Transplant Proc; 2007 Dec; 39(10):2970-4. PubMed ID: 18089302
[TBL] [Abstract][Full Text] [Related]
11. High plasma hemopexin activity is an independent risk factor for late graft failure in renal transplant recipients.
Krikken JA; van Ree RM; Klooster A; Seelen MA; Borghuis T; Lems SP; Schouten JP; Bakker WW; Gans RO; Navis G; Bakker SJ
Transpl Int; 2010 Aug; 23(8):805-12. PubMed ID: 20149159
[TBL] [Abstract][Full Text] [Related]
12. Serum procalcitonin predicting mortality in exertional heatstroke.
Tong HS; Liu YS; Wen Q; Tang YQ; Yuan FF; Su L
Emerg Med J; 2012 Feb; 29(2):113-7. PubMed ID: 21335580
[TBL] [Abstract][Full Text] [Related]
13. Post-operative kinetics of procalcitonin after lung transplantation.
Desmard M; Benbara A; Boudinet S; Mal H; Dehoux M; Thabut G; Montravers P
J Heart Lung Transplant; 2015 Feb; 34(2):189-94. PubMed ID: 25447581
[TBL] [Abstract][Full Text] [Related]
14. Procalcitonin in the setting of complicated postoperative course after liver transplantation.
Perrakis A; Yedibela S; Schellerer V; Hohenberger W; Müller V
Transplant Proc; 2010 Dec; 42(10):4187-90. PubMed ID: 21168660
[TBL] [Abstract][Full Text] [Related]
15. Kinetic of procalcitonin in the early postoperative course following heart transplantation.
Madershahian N; Wittwer T; Strauch J; Wippermann J; Rahmanian P; Franke UF; Wahlers T
J Card Surg; 2008; 23(5):468-73. PubMed ID: 18928484
[TBL] [Abstract][Full Text] [Related]
16. Combined use of myeloid-related protein 8/14 and procalcitonin as diagnostic markers for acute allograft rejection in kidney transplantation recipients.
Jung DY; Park JB; Lee EN; Lee HA; Joh JW; Kwon CH; Ki CS; Lee SY; Kim SJ
Transpl Immunol; 2008 Feb; 18(4):338-43. PubMed ID: 18158120
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin is a valuable prognostic marker in cardiac surgery but not specific for infection.
Dörge H; Schöndube FA; Dörge P; Seipelt R; Voss M; Messmer BJ
Thorac Cardiovasc Surg; 2003 Dec; 51(6):322-6. PubMed ID: 14669128
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of serum procalcitonin in solid organ transplant recipients: a systematic review and meta-analysis.
Yu XY; Wang Y; Zhong H; Dou QL; Song YL; Wen H
Transplant Proc; 2014; 46(1):26-32. PubMed ID: 24507021
[TBL] [Abstract][Full Text] [Related]
19. Predictive comparisons of procalcitonin (PCT) level, arterial ketone body ratio (AKBR), APACHE III score and multiple organ dysfunction score (MODS) in systemic inflammatory response syndrome (SIRS).
Lee YJ; Park CH; Yun JW; Lee YS
Yonsei Med J; 2004 Feb; 45(1):29-37. PubMed ID: 15004865
[TBL] [Abstract][Full Text] [Related]
20. Procalcitonin as a marker of micro-inflammation in hemodialysis.
Conti G; Amore A; Chiesa M; Mancuso D; Cirina P; Mengozzi G; Santoro A; Coppo R
J Nephrol; 2005; 18(3):282-8. PubMed ID: 16013016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
